Mum-of-five, Katie Price, 47, has warned her followers about the dangers of vaping, telling fans she needs to kick the habit ...

This infographic shows life expectancy at birth in selected G20 countries and worldwide between 1960 and 2023.

Pulmonary fibrosis—also known in technical terms as idiopathic pulmonary fibrosis (IPF)—is a rare but life-threatening ...

Home > Press release: Securing the protective caps of our DNA ... MHH researchers introduce mRNA with a building block for telomerase into human lung cells to reduce ageing processes and fibrosis ...

Researchers found that life expectancy growth in wealthy nations has dramatically slowed since 1939. Once driven by major reductions in child mortality, longevity gains are now limited by slower ...

Life expectancy is back to pre-pandemic levels, according to global health research — but mortality rates for teens and young adults are of growing concern. The latest release of The Global Burden of ...

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF). This is the first new therapy in more than 10 years to be approved for ...

Tvardi Therapeutics has failed its first big test as a public company. Months after joining the Nasdaq, the biotech has reported the unappetizing mix of high dropout rates and placebolike efficacy in ...

Nigeria has been ranked among the countries with the lowest life expectancy in the world, according to the latest data released by the United Nations’ World Population Prospects portal. The report ...

Please provide your email address to receive an email when new articles are posted on . The FDA based nerandomilast’s approval on results from two trials, one of which was the FIBRONEER-IPF trial.

More than 10 years after bringing one of the first idiopathic pulmonary fibrosis (IPF) drugs to market, Boehringer Ingelheim is freshening up its leadership in the rare lung disease space with a newly ...

What Is Jascayd, and Why Does It Matter? Jascayd (nerandomilast) is a new oral medicine approved to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF is a rare and serious condition that causes ...